Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Canagliflozin lowers HbA1c in children with T2D
16 Sep 2024
bởiStephen Padilla
Treatment with canagliflozin results in clinically meaningful reductions in glycated haemoglobin (HbA1c), when compared with placebo, in children and adolescents with type 2 diabetes (T2D), as shown by the results of a phase III study presented at EASD 2024.
Canagliflozin lowers HbA1c in children with T2D
16 Sep 2024
Tapinarof safe, efficacious for moderate-to-severe AD in children, adults
06 Sep 2024
bởiStephen Padilla
Treatment with tapinarof cream 1% once daily demonstrates significant efficacy with a favourable safety profile among adults and children with moderate-to-severe atopic dermatitis (AD), a study has shown.
Tapinarof safe, efficacious for moderate-to-severe AD in children, adults
06 Sep 2024
Dupilumab prevents atopic march progression in children with AD
06 Sep 2024
Use of dupilumab effectively lowers the risk of atopic march progression as opposed to conventional immunomodulatory therapies in paediatric patients with atopic dermatitis (AD), reports a recent study.